These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 19024136

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Hyperammonemia following intravenous valproate loading.
    DeWolfe JL, Knowlton RC, Beasley MT, Cofield S, Faught E, Limdi NA.
    Epilepsy Res; 2009 Jul; 85(1):65-71. PubMed ID: 19299111
    [Abstract] [Full Text] [Related]

  • 23. Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy.
    Tseng YL, Huang CR, Lin CH, Lu YT, Lu CH, Chen NC, Chang CC, Chang WN, Chuang YC.
    Medicine (Baltimore); 2014 Sep; 93(11):e66. PubMed ID: 25192484
    [Abstract] [Full Text] [Related]

  • 24. [Hyperammonemia in valproate therapy in children and adolescents].
    Laub MC.
    Nervenarzt; 1986 May; 57(5):314-8. PubMed ID: 3088461
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Gait instability in valproate-treated patients: Call to measure ammonia levels.
    Kipervasser S, Elger CE, Korczyn AD, Nass RD, Quesada CM, Neufeld MY.
    Acta Neurol Scand; 2017 Nov; 136(5):401-406. PubMed ID: 28436001
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Treatment of encephalopathy by means of valproic acid with carglumic acid: two case reports and a review of the literature].
    Nava-Mateos JJ, Roiz-Rey P, Diaz Alvarez-Mediavilla J, Cebrian-Novella D, Gomez-Del Olmo V, Ceberio-Hualde L.
    Rev Neurol; 2017 Nov 01; 65(9):409-414. PubMed ID: 29071700
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB, Kutlu G, Cavdar L, Sanivar F, Inan LE.
    Epilepsy Behav; 2007 Jun 01; 10(4):583-7. PubMed ID: 17412645
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Is valproate encephalopathy under-recognised in older people? A case series.
    Beyenburg S, Back C, Diederich N, Lewis M, Reuber M.
    Age Ageing; 2007 May 01; 36(3):344-6. PubMed ID: 17374600
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
    Rigamonti A, Lauria G, Grimod G, Bianchi G, Salmaggi A.
    J Clin Neurosci; 2014 Apr 01; 21(4):690-1. PubMed ID: 24119342
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.